Amyloid-Beta-Activated Human Microglial Cells Through ER-Resident Proteins

• DOI: 10.1021/pr500926r
• Publication Date: 2014-10-30T01:12:22Z
• Authors: YongCheol Yoo; Kyunghee Byun; Taewook Kang; Delger Bayarsaikhan; Jin Young Kim; Seyeoun Oh; Young Hye Kim; Se-Young Kim; Won-Il Chung; Seung U. Kim; Bonghee Lee; Young Mok Park
• Keywords: Proteomics; 0301 basic medicine; Amyloid beta-Peptides; Proteome; Molecular Sequence Data; 610; Gene Expression; Membrane Proteins; Endoplasmic Reticulum; Cell Line; 3. Good health; Mice; 03 medical and health sciences; Gene Ontology; Alzheimer Disease; Tandem Mass Spectrometry; QUANTITATIVE PROTEOMIC ANALYSIS; ALZHEIMERS-DISEASE; PROGRANULIN EXPRESSION; MOLECULAR CHAPERONE; PRECURSOR PROTEIN; STRESS; BRAIN; NRF2; PATHOGENESIS; CLEARANCE; Protein Interaction Mapping; Animals; Humans; Amino Acid Sequence; Microglia; Biomarkers

Microglial activation in the central nervous system is a key event in the neuroinflammation that accompanies neurodegenerative diseases such as Alzheimer's disease (AD). Among cytokines involved in microglial activation, amyloid β (Aβ) peptide is known to be a key molecule in the induction of diverse inflammatory products, which may lead to chronic inflammation in AD. However, proteomic studies of microglia in AD are limited due to lack of proper cell or animal model systems. In this study, we performed a proteomic analysis of Aβ-stimulated human microglial cells using SILAC (stable isotope labeling with amino acids in cell culture) combined with LC-MS/MS. Results showed that 60 proteins increased or decreased their abundance by 1.5 fold or greater. Among these, ER-resident proteins such as SERPINH1, PDIA6, PDIA3, and PPIB were revealed to be key molecular biomarkers of human microglial activation by validation of the proteomic results by immunostaining, PCR, ELISA, and Western blot. Taken together, our data suggest that ER proteins play an essential role in human microglial activation by Aβ and may be important molecular therapeutic targets for treatment of AD.